PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- A Race Against Blindness, a nonprofit organization dedicated to funding sight-saving therapies for children, is thrilled to announce a $2.0 million grant was awarded in December 2024 to Axovia Therapeutics to support a planned clinical trial for the company’s product candidate, AXV101, aimed at combating childhood blindness due to retinitis pigmentosa (RP) caused by Bardet-Biedl Syndrome 1 (BBS1). With this grant, the charity contributed $3.0 million in total fundi ...